Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

38 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Incidence and immunomic features of apyretic COVID-19 in patients affected by solid tumors: a prospective cohort study.
Ravera F, Borea R, Cirmena G, Dameri M, Ferrando L, Gallo M, Casini C, Fallani N, Stabile M, Barbero V, Murialdo R, Tixi L, Cappuccio M, Cuboni A, Sivieri I, Fornarini G, De Maria A, Ballestrero A, Zoppoli G. Ravera F, et al. Among authors: cirmena g. J Transl Med. 2022 May 14;20(1):230. doi: 10.1186/s12967-022-03429-0. J Transl Med. 2022. PMID: 35568887 Free PMC article.
Immunotherapy with dendritic cells for cancer.
Ballestrero A, Boy D, Moran E, Cirmena G, Brossart P, Nencioni A. Ballestrero A, et al. Among authors: cirmena g. Adv Drug Deliv Rev. 2008 Jan 14;60(2):173-83. doi: 10.1016/j.addr.2007.08.026. Epub 2007 Oct 5. Adv Drug Deliv Rev. 2008. PMID: 17977615 Review.
Ras-induced resistance to lapatinib is overcome by MEK inhibition.
Zoppoli G, Moran E, Soncini D, Cea M, Garuti A, Rocco I, Cirmena G, Grillo V, Bagnasco L, Icardi G, Ansaldi F, Parodi S, Patrone F, Ballestrero A, Nencioni A. Zoppoli G, et al. Among authors: cirmena g. Curr Cancer Drug Targets. 2010 Mar;10(2):168-75. doi: 10.2174/156800910791054211. Curr Cancer Drug Targets. 2010. PMID: 20088787
Quantitative Real Time PCR assessment of hormonal receptors and HER2 status on fine-needle aspiration pre-operatory specimens from a prospectively accrued cohort of women with suspect breast malignant lesions.
Garuti A, Rocco I, Cirmena G, Chiaramondia M, Baccini P, Calabrese M, Palermo C, Friedman D, Zoppoli G, Ballestrero A. Garuti A, et al. Among authors: cirmena g. Gynecol Oncol. 2014 Feb;132(2):389-96. doi: 10.1016/j.ygyno.2013.11.020. Epub 2013 Nov 21. Gynecol Oncol. 2014. PMID: 24269902
Her2 assessment using quantitative reverse transcriptase polymerase chain reaction reliably identifies Her2 overexpression without amplification in breast cancer cases.
Zoppoli G, Garuti A, Cirmena G, di Cantogno LV, Botta C, Gallo M, Ferraioli D, Carminati E, Baccini P, Curto M, Fregatti P, Isnaldi E, Lia M, Murialdo R, Friedman D, Sapino A, Ballestrero A. Zoppoli G, et al. Among authors: cirmena g. J Transl Med. 2017 May 1;15(1):91. doi: 10.1186/s12967-017-1195-7. J Transl Med. 2017. PMID: 28460632 Free PMC article.
Clinico-pathological associations and concomitant mutations of the RAS/RAF pathway in metastatic colorectal cancer.
Isnaldi E, Garuti A, Cirmena G, Scabini S, Rimini E, Ferrando L, Lia M, Murialdo R, Tixi L, Carminati E, Panaro A, Gallo M, Grillo F, Mastracci L, Repetto L, Fiocca R, Romairone E, Zoppoli G, Ballestrero A. Isnaldi E, et al. Among authors: cirmena g. J Transl Med. 2019 Apr 29;17(1):137. doi: 10.1186/s12967-019-1879-2. J Transl Med. 2019. PMID: 31036005 Free PMC article.
38 results